期刊文献+

小儿再生障碍性贫血合并骨髓细胞病态造血现象的临床分析 被引量:2

Clinical analysis on pediatric aplastic anemia combined with morbid hematopoiesis of bone marrow cells
下载PDF
导出
摘要 目的分析小儿再生障碍性贫血合并骨髓细胞病态造血现象。方法选取资阳市第一人民医院2014年3月至2017年3月收治的40例再生障碍性贫血患儿作为A组,骨髓增生异常综合征患儿38例作为B组,再生障碍性贫血合并骨髓细胞病态造血患儿30例为C组,另选择同时期收治的来院体检的35例健康儿作为对照组,A组、B组及C组患儿采用对应的治疗方法,测定并比较治疗前后CD34+、叶酸及维生素B12的水平。结果治疗前,A组、B组、C组与对照组相比CD34+、叶酸及维生素B12的水平均较低,C组与A组、B组相比CD34+降低更加显著,A组与B组相比CD34+降低更加显著,差异具有统计学意义(t=2.34~6.57,均P<0.05),A组、B组及C组叶酸及维生素B12的水平分别相比无明显差异(t=0.87~1.01,均P>0.05);治疗后,A组、B组及C组CD34+、叶酸及维生素B12水平均有所升高,但低于对照组,差异具有统计学意义(t=4.90~6.38,均P<0.05)。A组、B组及C组治疗后CD34+、叶酸及维生素B12的水平相比无明显差异(t=0.56~0.88,均P>0.05)。结论小儿再生障碍性贫血合并骨髓细胞病态造血的血清学指标具有特殊,建议对患儿的血清叶酸及维生素B12的水平进行合理的检测和针对性治疗。 Objective To explore pediatric aplastic anemia combined with morbid hematopoiesis of bone marrow cells.Methods Forty cases of aplastic anemia children admitted in Ziyang First People's Hospital from March 2014 to March 2017 were selected in group A,38 cases of myelodysplastic syndromes(MDS)were selected in group B,and 30 children with aplastic anemia combined with morbid hematopoiesis of bone marrow cells in group C.At the same period,35 healthy children receiving physical check in the hospital were selected in control group.Patients in group A,B and C were treated with corresponding treatment.Levels of CD34+,folic acid and vitamin B12 in three groups were detected and compared before and after the treatment.Results Levels of CD34+,folic acid and vitamin B12 in group A,B and C were lower than those in the control group before treatment,level of CD34+in group C was lower than that in group A and B,and level of CD34+in group A was lower than that in group B with significant differences(t value ranged 2.34-6.57,all P〈0.05).Folic acid and vitamin B12 levels had no significant differences among group A,B and C(t value ranged 0.87-1.01,all P〈0.05).Levels of CD34+,folic acid and vitamin B12 in group A,B and C were all increased after treatment but still lower than those in the control group,and differences were statistically significant(t value ranged 4.90-6.38,all P〈0.05).Levels of CD34+,folic acid and vitamin B12 in group A,B and C after treatment had no significant difference(t value ranged 0.56-0.88,all P〈0.05).Conclusion Serological indicators of patients with pediatric aplastic anemia combined with morbid hematopoiesis of marrow cells are specific.Detection of patient's serum levels of folic acid and vitamin B12 and targeted therapy are suggested.
作者 朱萍 郑红
出处 《中国妇幼健康研究》 2017年第11期1387-1388,1400,共3页 Chinese Journal of Woman and Child Health Research
关键词 小儿再生障碍性贫血 骨髓细胞病态造血现象 临床分析 早期诊断 pediatric aplastic anemia morbid hematopoiesis of bone marrow cells clinical analysis early diagnosis
  • 相关文献

参考文献6

二级参考文献56

  • 1张之楠,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2007:271-271.
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 3Caslini C, Serna A, Rossi V, et al. Modulation of cell cycle by gra- ded expression of MLL-AF4 fusion oncoprotein. Leukemia, 2004;18 (6) : 1064 - 1071.
  • 4刘宏.高白细胞白血病48例临床分析.中外健康文摘,2012;09(22):186-187.
  • 5Stone RM, DeAngelo DJ, Janosova A, et al. Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission. Am J Hematol, 2008 ; 83(10) :771 -777.
  • 6Maritz MF, Napier CE, Wen VW. et al. Targeting telomerase in hema- tologic malignancy. Futuer Oncol 2010 ;6 (9) :769 -789.
  • 7Hiddeman W, Kern W, Schoch C, et al. Management of acute mye- loid leukemia in elderly patients. J Clin Oncol, 1999 ; 17 ( I 1 ) : 3569 - 3576.
  • 8刘亚琳,刘海波,王雯娟,刘华胜.高白细胞急性白血病的骨髓细胞学特点对照分析.中华血液学杂志,2012;9(33)增刊.141论文摘要.
  • 9Ali Bay, Mehmet Keskin,Samil Hizli, et al. Thiamine-responsive megaloblastic anemia syndrome[J]. International Journal of He matology,2010,92 (3) :524-526.
  • 10Giagounidis A, Haase D. Morphology, cytogenetics and classification of MDS[J]. Best Pract Res Clin Haematol. 2013,26 (4):337-353.

共引文献66

同被引文献18

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部